Company Name, Ticker, Competitors, else..

Ani Pharmaceuticals inc (ANIP)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry ../Industry/industry_growth_rates.php?cfw&ind=803"> • Major Pharmaceutical Preparations

Sector • Healthcare

Ani Pharmaceuticals inc

ANIP's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

ANIP Growth rates comparisons

Looking into Ani Pharmaceuticals Inc growth rates, revenue grew by 57.02 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1825

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.83 %

Ani Pharmaceuticals Inc net loss deacreased by in IV. Quarter 2022 year on year, Ani Pharmaceuticals Inc net loss increased by -85.38 % in IV. Quarter 2022 year on year,

• More on ANIP's Growth

ANIP's Valuation comparisons

Ani Pharmaceuticals Inc
realized net loss in trailing twelve months.

Ani Pharmaceuticals Inc realized cash outflow of $ -2.71per share in trailing twelve-month period.

Company

-

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 2.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.44.

• More on ANIP's Valuation

Total Debt (Millions $)	287
Dividend TTM ($)	0.09 $
Dividend Yield TTM (%)	0.23 %
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	2.15
Tangible Book Value (Per Share $)	2.08

ANIP's Valuation comparisons

Ani Pharmaceuticals Inc
realized net loss in trailing twelve months.

Ani Pharmaceuticals Inc realized cash outflow of $ -2.71per share in trailing twelve-month period.

Company

-

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 2.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.44.

Ani Pharmaceuticals Inc Price to Book Ratio is at 2.04 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on ANIP's Valuation

• Market Capitalization (Millions $)	639
• Shares Outstanding (Millions)	16
• Employees	-
• Revenues (TTM) (Millions $)	316
• Net Income (TTM) (Millions $)	-48
• Cash Flow (TTM) (Millions $)	-
• Capital Exp. (TTM) (Millions $)	-
• Total Debt (Millions $)	287
• Dividend TTM ($)	0.09 $
• Dividend Yield TTM (%)	0.23 %
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	2.15
• Tangible Book Value (Per Share $)	2.08

• Market Capitalization (Millions $)	639
• Shares Outstanding (Millions)	16
• Employees	-
• Revenues (TTM) (Millions $)	316
• Net Income (TTM) (Millions $)	-48
• Cash Flow (TTM) (Millions $)	-
• Capital Exp. (TTM) (Millions $)	-

ANIP's Profitability Comparisons
Ani Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 1.93 %.

	*Ratio*
• Capital Ratio (MRQ)	3.46
• Total Debt to Equity (MRQ)	0.91
• Tangible Leverage Ratio (MRQ)	13.19
• Asset Turnover Ratio (TTM)	0.42
• Inventory Turnover Ratio (TTM)	1.47

ANIP's Profitability Comparisons

Ani Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 1.93 %.

• More on ANIP's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MMEX's Profile Stock Price MMEX's Financials Business Description Fundamentals Charts & Quotes MMEX's News Suppliers MMEX's Competitors Customers & Markets Economic Indicators MMEX's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071